Evidence map›Paper›PMID 27165128›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2016

Feruloylated Oligosaccharides from Maize Bran Modulated the Gut Microbiota in Rats.

Juan-Ying Ou, Jun-Qing Huang, Yuan Song, Sheng-Wen Yao, Xi-Chun Peng, Ming-Fu Wang, Shi-Yi Ou

Abstract read
PubMed Publisher
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Research on the Mechanism and Material Basis of Corn (Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Juan-Ying OuFood and Nutritional Science Program, School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
Jun-Qing HuangInstitute of Integrated Chinese and Western Medicine, Medical College of Jinan University, Guangzhou, 510632, China.
Yuan SongInstitute of Integrated Chinese and Western Medicine, Medical College of Jinan University, Guangzhou, 510632, China.
Sheng-Wen YaoDepartment of Food Science and Engineering, Jinan University, Guangzhou, Guangdong, 510632, China.
Xi-Chun PengDepartment of Food Science and Engineering, Jinan University, Guangzhou, Guangdong, 510632, China.
Ming-Fu WangFood and Nutritional Science Program, School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
Shi-Yi OuDepartment of Food Science and Engineering, Jinan University, Guangzhou, Guangdong, 510632, China. tosy@jnu.edu.cn.
Jinan University · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corn bran is a byproduct produced from corn milling; it is rich in ferulic acid and hemicellulose. In this research, the effects of feruloylated oligosaccharides (FOs) from maize bran on the microbial diversity and profiles in rat feces were investigated through 16S rRNA sequencing. FOs significantly increased bacterial richness and diversity compared with the control and xylooligosaccharides (XOS) alone. In comparison with the control group and the group administrated with XOS, FOs orally administered at 300 mg/kg increased OTU in feces by 57.0 and 24.8 %, and Chao value by 93.4 and 37.6 %, respectively. FOs also influenced obesity- and diabetes-associated bacteria. Oral administration of FOs at 300 mg/kg decreased the ratio of Firmicutes to Bacteroidetes from 477.7:1 to 55.1:1; greatly increased the reads of bacteria that were previously found resistant against diabetes in rats, such as Actinobacteria, Bacteroides, and Lactobacillus; whereas decreased diabetes-prone bacteria, such as Clostridium and Firmicutes.

Indexed as

Administration, OralAnimalsBacillotaBacteriaBacteroidetesCoumaric AcidsDietary FiberFecesGastrointestinal MicrobiomeGlucuronatesLigninMaleOligosaccharidesPolysaccharidesRatsRNA, Ribosomal, 16SCoumaric AcidsDietary Fiberferulic acidGlucuronateshemicelluloseLigninlignocelluloseOligosaccharidesPolysaccharidesRNA, Ribosomal, 16SxylooligosaccharideDiabetesFeruloylated oligosaccharideMicrobiotaObesity

Identifiers

PMID27165128
OpenAlexW2361807195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.